Showing results (661-670 of 2,281) with videos related to
Sort By:
Pageof 229
HIV Medicine|October 20, 2022
Impact of COVID-19 on HIV late diagnosis in a specialized German centreKathrin van Bremen, Malte Monin, Stefan Schlabe, et al.HIV Medicine|October 26, 2022
Associations between HIV infection and frailty status and its individual components: Are frailty components disproportionally affected?Jing Li, Xiaoxiao Chen, Haijiang Lin, et al.HIV Medicine|December 23, 2021
Tuberculosis incidence in country of origin is a key determinant of the risk of active tuberculosis in people living with HIV: Data from a 30-year observational cohort studyHelena A White, Hajra Okhai, Peter Kirwan, et al.HIV Medicine|March 25, 2021
Failure to eradicate Helicobacter pylori infection is more frequent among HIV-positive patientsM Nkuize, J Vanderpas, M Buset, et al.HIV Medicine|September 20, 2022
Changing co-morbidity and increasing deprivation among people living with HIV: UK population-based cross-sectional studyPatricia McGettigan, Daniel R Morales, David Moreno-Martos, et al.HIV Medicine|May 4, 2011
Morbidity in HIV-1-infected individuals before and after the introduction of antiretroviral therapy: a longitudinal study of a population-based cohort in UgandaC C Iwuji, B N Mayanja, H A Weiss, et al.HIV Medicine|September 8, 2015
Hospitalisation rates and associated factors in community-based cohorts of HIV-infected and -uninfected gay and bisexual menC L Moore, A E Grulich, G Prestage, et al.HIV Medicine|January 15, 2015
The Intelence aNd pRezista Once A Day Study (INROADS): a multicentre, single-arm, open-label study of etravirine and darunavir/ritonavir as dual therapy in HIV-1-infected early treatment-experienced subjectsP J Ruane, C Brinson, M Ramgopal, et al.HIV Medicine|January 27, 2016
Timing Matters - Influenza Vaccination to HIV-Infected PatientsE R Glinka, D M Smith, S T JohnsPageof 229